Study of the Havelhöhe Community Hospital on interventions for irritable bowel syndrome in the context of short-term therapy

Not Applicable

• Conditions: K58; F41; F32; Irritable bowel syndrome; Other anxiety disorders; Depressive episode

• Registration Number: DRKS00016890
• Lead Sponsor: Gemeinschaftskrankenhaus Havelhöhe gGmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-12-06
• Study Start: 2022-03-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

Diagnosed irritable bowel syndrome

Exclusion Criteria

Participation in other studies

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-reported irritable bowel syndrome severity measured on paper using the validated IBS-SSS by Francis et al. (1997) and the German version by Betz et al. (2013).<br>Collected at the start of the intervention (baseline) on day 1, after completion of the intervention (post-AMT) on day 12 and after 12 months (follow-up-UP).

Secondary Outcome Measures

Name	Time	Method
Self-reported depressive symptomatology measured with the paper version of the PHQ-9, the anxiety symptomatology with the GAD-7 and the self-reported satisfaction and efficacy with therapy, using a newly developed patient-reported outcome questionnaire (PREM).